Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Gut ; 57(8): 1102-12, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18303091

RESUMO

BACKGROUND AND AIMS: Acute pancreatitis is associated with significant morbidity and mortality. Bile reflux into the pancreas is a common cause of acute pancreatitis and, although the bile can reach both acinar and ductal cells, most research to date has focused on the acinar cells. The aim of the present study was to investigate the effects of bile acids on HCO(3)(-) secretion from the ductal epithelium. METHODS: Isolated guinea pig intralobular/interlobular pancreatic ducts were microperfused and the effects of unconjugated chenodeoxycholate (CDC) and conjugated glycochenodeoxycholate (GCDC) on intracellular calcium concentration ([Ca(2+)](i)) and pH (pH(i)) were measured using fluorescent dyes. Changes of pH(i) were used to calculate the rates of acid/base transport across the duct cell membranes. RESULTS: Luminal administration of a low dose of CDC (0.1 mM) stimulated ductal HCO(3)(-) secretion, which was blocked by luminal H(2)DIDS (dihydro-4,4'-diisothiocyanostilbene-2,2'-disulfonic acid). In contrast, both luminal and basolateral administration of a high dose of CDC (1 mM) strongly inhibited HCO(3)(-) secretion. Both CDC and GCDC elevated [Ca(2+)](i), and this effect was blocked by BAPTA-AM (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid), caffeine, xestospongin C and the phospholipase C inhibitor U73122. BAPTA-AM also inhibited the stimulatory effect of low doses of CDC on HCO(3)(-) secretion, but did not modulate the inhibitory effect of high doses of CDC. CONCLUSIONS: It is concluded that the HCO(3)(-) secretion stimulated by low concentrations of bile acids acts to protect the pancreas against toxic bile, whereas inhibition of HCO(3)(-) secretion by high concentrations of bile acids may contribute to the progression of acute pancreatitis.


Assuntos
Bicarbonatos/metabolismo , Ácidos e Sais Biliares/farmacologia , Ductos Pancreáticos/efeitos dos fármacos , Doença Aguda , Animais , Cálcio/metabolismo , Ácido Quenodesoxicólico/farmacologia , Antiportadores de Cloreto-Bicarbonato/metabolismo , Relação Dose-Resposta a Droga , Ácido Glicoquenodesoxicólico/farmacologia , Cobaias , Concentração de Íons de Hidrogênio/efeitos dos fármacos , Dados de Sequência Molecular , Ductos Pancreáticos/citologia , Ductos Pancreáticos/metabolismo , Técnicas de Cultura de Tecidos
2.
Am J Physiol Gastrointest Liver Physiol ; 284(2): G328-39, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12388191

RESUMO

Proliferation and carcinogenesis of the large intestinal epithelial cells (IEC) cells is significantly increased in transgenic mice that overexpress the precursor progastrin (PG) peptide. It is not known if the in vivo growth effects of PG on IEC cells are mediated directly or indirectly. Full-length recombinant human PG (rhPG(1-80)) was generated to examine possible direct effects of PG on IEC cells. Surprisingly, rhPG (0.1-1.0 nM) was more effective than the completely processed gastrin 17 (G17) peptide as a growth factor. Even though IEC cells did not express CCK(1) and CCK(2) receptors (-R), fluorescently labeled G17 and Gly-extended G17 (G-Gly) were specifically bound to the cells, suggesting the presence of binding proteins other than CCK(1)-R and CCK(2)-R on IEC cells. High-affinity (K(d) = 0.5-1.0 nM) binding sites for (125)I-rhPG were discovered on IEC cells that demonstrated relative binding affinity for gastrin-like peptides in the order PG >or= COOH-terminally extended G17 >or= G-Gly > G17 > *CCK-8 (* significant difference; P < 0.05). In conclusion, our studies demonstrate for the first time direct growth effects of the full-length precursor peptide on IEC cells in vitro that are apparently mediated by the high-affinity PG binding sites that were discovered on these cells.


Assuntos
Gastrinas/farmacologia , Mucosa Intestinal/metabolismo , Precursores de Proteínas/farmacologia , Aminoácidos/metabolismo , Animais , Sítios de Ligação , Ligação Competitiva/efeitos dos fármacos , Células Cultivadas , Cromatografia Líquida de Alta Pressão , DNA Complementar/biossíntese , DNA Complementar/genética , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Escherichia coli/metabolismo , Corantes Fluorescentes , Gastrinas/metabolismo , Técnicas In Vitro , Mucosa Intestinal/citologia , Mucosa Intestinal/efeitos dos fármacos , Cinética , Espectrometria de Massas , Camundongos , Camundongos Transgênicos , Microscopia Confocal , RNA Mensageiro/biossíntese , Receptor de Colecistocinina B , Receptores da Colecistocinina/metabolismo , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/farmacologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Estimulação Química
3.
Eur J Med Chem ; 36(6): 495-506, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11525840

RESUMO

Ambasilide, a representative of Class III antiarrhythmics, was reported to prolong the cardiac action potential duration in the dog, with little or no effect on Ca and Na currents. We synthesised a series of ambasilide analogues, having the 3,8-diazabicyclo-[3.2.1]-octane moiety instead of the 3,7-diazabicyclo-[3.3.1]-nonane present in ambasilide. The compounds were tested both in vitro extracellular electrophysiological assays and by the conventional microelectrode technique. Most of them lengthened the effective refractory period (ERP) with no change or slight increase on the impulse conduction time (ICT). Similarly some of the tested compounds lengthened the action potential duration (APD), a typical Class III feature, without exerting any significant effect on the maximal rate of depolarization, therefore apparently lacking Class I antiarrhythmic activity.


Assuntos
Aminobenzoatos/química , Aminobenzoatos/farmacologia , Antiarrítmicos/química , Antiarrítmicos/síntese química , Antiarrítmicos/farmacologia , Compostos Bicíclicos Heterocíclicos com Pontes/química , Compostos Bicíclicos Heterocíclicos com Pontes/farmacologia , Ventrículos do Coração/efeitos dos fármacos , Aminobenzoatos/síntese química , Animais , Compostos Bicíclicos Heterocíclicos com Pontes/síntese química , Cães , Desenho de Fármacos , Técnicas Eletrofisiológicas Cardíacas , Feminino , Técnicas In Vitro , Masculino , Microeletrodos , Modelos Moleculares , Conformação Molecular , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA